Cargando…
Development and investigational new drug application of mesenchymal stem/stromal cells products in China
Mesenchymal stem/stromal cells (MSCs) have broad application prospects for regenerative medicine due to their self‐renewal, high plasticity, ability for differentiation, and immune response and modulation. Interest in turning MSCs into clinical applications has never been higher than at present. Man...
Autores principales: | Zhao, Qinjun, Han, Zhibo, Wang, Jialun, Han, Zhongchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560202/ https://www.ncbi.nlm.nih.gov/pubmed/34724720 http://dx.doi.org/10.1002/sctm.21-0083 |
Ejemplares similares
-
Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells‐based therapy product
por: Jha, Balendu Shekhar, et al.
Publicado: (2020) -
Preclinical translation of exosomes derived from mesenchymal stem/stromal cells
por: Elahi, Fanny M., et al.
Publicado: (2019) -
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
por: Weng, Zhijie, et al.
Publicado: (2022) -
Orchestration of Mesenchymal Stem/Stromal Cells and Inflammation During Wound Healing
por: Zhu, Mengting, et al.
Publicado: (2023) -
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment
por: Frisbie, Len, et al.
Publicado: (2022)